Stephen Willey
Stock Analyst at Stifel
(3.72)
# 730
Out of 5,134 analysts
130
Total ratings
42.11%
Success rate
11.33%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Stephen Willey
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| IRON Disc Medicine | Maintains: Buy | $125 → $110 | $64.32 | +71.02% | 2 | Feb 17, 2026 | |
| INCY Incyte | Maintains: Buy | $119 → $120 | $100.30 | +19.64% | 8 | Feb 11, 2026 | |
| EXEL Exelixis | Maintains: Hold | $43 → $44 | $44.02 | -0.05% | 20 | Feb 11, 2026 | |
| NRIX Nurix Therapeutics | Maintains: Buy | $33 → $35 | $15.34 | +128.16% | 6 | Jan 29, 2026 | |
| ZYME Zymeworks | Maintains: Buy | $30 → $40 | $23.02 | +73.76% | 7 | Nov 19, 2025 | |
| CELC Celcuity | Maintains: Buy | $68 → $115 | $103.70 | +10.90% | 2 | Nov 13, 2025 | |
| NKTX Nkarta | Maintains: Buy | $12 → $11 | $2.07 | +431.40% | 5 | Nov 11, 2025 | |
| ACLX Arcellx | Reinstates: Buy | $129 | $69.50 | +85.61% | 1 | Oct 16, 2025 | |
| XFOR X4 Pharmaceuticals | Maintains: Buy | $30 → $9 | $3.29 | +173.97% | 3 | Aug 29, 2025 | |
| INSM Insmed | Maintains: Buy | $121 → $145 | $151.05 | -4.01% | 8 | Aug 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $8 → $7 | $3.08 | +127.27% | 7 | Aug 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $28 | $9.13 | +206.68% | 1 | Jun 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $6 → $5 | $1.72 | +191.55% | 4 | May 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $25 → $20 | $4.96 | +303.23% | 4 | May 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $240 → $100 | $13.15 | +660.46% | 5 | Mar 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $8 → $4 | $1.76 | +127.92% | 3 | Feb 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $47 | $14.27 | +229.36% | 1 | Oct 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $8 → $4 | $0.30 | +1,248.62% | 7 | Aug 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $3 → $4 | $1.69 | +136.69% | 1 | Dec 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $53 → $62 | $41.63 | +48.95% | 5 | Dec 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $9 | $6.43 | +39.97% | 1 | Jan 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $12 | $1.71 | +603.81% | 1 | Nov 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $228 → $288 | $1.63 | +17,623.08% | 4 | Jun 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $22 → $21 | $2.35 | +793.62% | 2 | Mar 17, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $10 → $4 | $1.34 | +199.63% | 7 | Jul 29, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $125 → $123 | $332.52 | -63.01% | 3 | Aug 13, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $48 → $47 | $82.06 | -42.72% | 2 | Aug 8, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $102 → $109 | $59.94 | +81.85% | 3 | Aug 3, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Terminates: Hold | n/a | $23.57 | - | 2 | Jun 25, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 → $23 | $11.04 | +108.33% | 5 | Feb 7, 2018 |
Disc Medicine
Feb 17, 2026
Maintains: Buy
Price Target: $125 → $110
Current: $64.32
Upside: +71.02%
Incyte
Feb 11, 2026
Maintains: Buy
Price Target: $119 → $120
Current: $100.30
Upside: +19.64%
Exelixis
Feb 11, 2026
Maintains: Hold
Price Target: $43 → $44
Current: $44.02
Upside: -0.05%
Nurix Therapeutics
Jan 29, 2026
Maintains: Buy
Price Target: $33 → $35
Current: $15.34
Upside: +128.16%
Zymeworks
Nov 19, 2025
Maintains: Buy
Price Target: $30 → $40
Current: $23.02
Upside: +73.76%
Celcuity
Nov 13, 2025
Maintains: Buy
Price Target: $68 → $115
Current: $103.70
Upside: +10.90%
Nkarta
Nov 11, 2025
Maintains: Buy
Price Target: $12 → $11
Current: $2.07
Upside: +431.40%
Arcellx
Oct 16, 2025
Reinstates: Buy
Price Target: $129
Current: $69.50
Upside: +85.61%
X4 Pharmaceuticals
Aug 29, 2025
Maintains: Buy
Price Target: $30 → $9
Current: $3.29
Upside: +173.97%
Insmed
Aug 14, 2025
Maintains: Buy
Price Target: $121 → $145
Current: $151.05
Upside: -4.01%
Aug 8, 2025
Maintains: Buy
Price Target: $8 → $7
Current: $3.08
Upside: +127.27%
Jun 25, 2025
Initiates: Buy
Price Target: $28
Current: $9.13
Upside: +206.68%
May 14, 2025
Maintains: Hold
Price Target: $6 → $5
Current: $1.72
Upside: +191.55%
May 13, 2025
Maintains: Hold
Price Target: $25 → $20
Current: $4.96
Upside: +303.23%
Mar 21, 2025
Maintains: Buy
Price Target: $240 → $100
Current: $13.15
Upside: +660.46%
Feb 27, 2025
Maintains: Buy
Price Target: $8 → $4
Current: $1.76
Upside: +127.92%
Oct 8, 2024
Initiates: Buy
Price Target: $47
Current: $14.27
Upside: +229.36%
Aug 20, 2024
Maintains: Buy
Price Target: $8 → $4
Current: $0.30
Upside: +1,248.62%
Dec 19, 2023
Maintains: Buy
Price Target: $3 → $4
Current: $1.69
Upside: +136.69%
Dec 18, 2023
Maintains: Buy
Price Target: $53 → $62
Current: $41.63
Upside: +48.95%
Jan 27, 2023
Initiates: Buy
Price Target: $9
Current: $6.43
Upside: +39.97%
Nov 28, 2022
Initiates: Buy
Price Target: $12
Current: $1.71
Upside: +603.81%
Jun 26, 2020
Downgrades: Hold
Price Target: $228 → $288
Current: $1.63
Upside: +17,623.08%
Mar 17, 2020
Maintains: Buy
Price Target: $22 → $21
Current: $2.35
Upside: +793.62%
Jul 29, 2019
Downgrades: Hold
Price Target: $10 → $4
Current: $1.34
Upside: +199.63%
Aug 13, 2018
Maintains: Buy
Price Target: $125 → $123
Current: $332.52
Upside: -63.01%
Aug 8, 2018
Maintains: Hold
Price Target: $48 → $47
Current: $82.06
Upside: -42.72%
Aug 3, 2018
Maintains: Buy
Price Target: $102 → $109
Current: $59.94
Upside: +81.85%
Jun 25, 2018
Terminates: Hold
Price Target: n/a
Current: $23.57
Upside: -
Feb 7, 2018
Maintains: Buy
Price Target: $20 → $23
Current: $11.04
Upside: +108.33%